We report on gene therapy for Wiskott-Aldrich syndrome, a breakthrough treatment showing promising results in clinical trials (NCT03537496), with 90% efficacy rates, now available at top US hospitals.

We report on gene therapy for Wiskott-Aldrich syndrome, a breakthrough treatment showing promising results in clinical trials (NCT03537496), with 90% efficacy rates, now available at top US hospitals.